Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Interim results of a phase II study of blinatumomab plus ponatinib for...

Prof Nicholas Short - The University of Texas MD Anderson Cancer Center...

Interim results of a phase II study of blinatumomab plus ponatinib for Philadelphia chromosome-positive ALL ( Prof Nicholas Short - The University of Texas MD Anderson Cancer Center, Houston, USA )

Phase II study of blinatumomab for MRD-positive B-cell acute lymphoblastic...

Prof Nicholas Short - The University of Texas MD Anderson Cancer Center...

Phase II study of blinatumomab for MRD-positive B-cell acute lymphoblastic leukaemia ( Prof Nicholas Short - The University of Texas MD Anderson Cancer Center, Houston, USA )

EHA 2021: Latest in immunotherapy for R/R multiple myeloma

Prof Evangelos Terpos, Prof Heinz Ludwig, Prof Meral Beksac and Prof Michele...

EHA 2021: Latest in immunotherapy for R/R multiple myeloma ( Prof Evangelos Terpos, Prof Heinz Ludwig, Prof Meral Beksac and Prof Michele Cavo )

ALCSI: Raising lung cancer screening awareness in the US

Priyanka Senthil - American Lung Cancer Screening Initiative

ALCSI: Raising lung cancer screening awareness in the US ( Priyanka Senthil - American Lung Cancer Screening Initiative )

OncoAlert and ecancer ASCO roundup - Day 4 and 5

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer ASCO roundup - Day 4 and 5 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

ADT plus TAK-700 with ADT plus bicalutamide in patients with newly diagnosed...

Prof Neeraj Agarwal - Huntsman Cancer Institute, University of Utah, Salt Lake...

ADT plus TAK-700 with ADT plus bicalutamide in patients with newly diagnosed mHSPC ( Prof Neeraj Agarwal - Huntsman Cancer Institute, University of Utah, Salt Lake City, USA )

A comparison of clinical outcomes from ZUMA-5 and the international scholar-5...

Prof Paola Ghione - Roswell Park Comprehensive Cancer Center, Buffalo, USA

A comparison of clinical outcomes from ZUMA-5 and the international scholar-5 external control cohort in R/R FL ( Prof Paola Ghione - Roswell Park Comprehensive Cancer Center, Buffalo, USA )

GLOW: Fixed-duration ibrutinib and venetoclax for first-line CLL

Prof Arnon Kater - Amsterdam University Medical Centre, Amsterdam, The...

GLOW: Fixed-duration ibrutinib and venetoclax for first-line CLL ( Prof Arnon Kater - Amsterdam University Medical Centre, Amsterdam, The Netherlands )

Brentuximab vedotin with chemotherapy for advanced classical Hodgkin lymphoma

Dr Martin Hutchings - Copenhagen University Hospital, Copenhagen, Denmark

Brentuximab vedotin with chemotherapy for advanced classical Hodgkin lymphoma ( Dr Martin Hutchings - Copenhagen University Hospital, Copenhagen, Denmark )

Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or...

Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA

Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )

Using a novel cervical precancer screening approach to detect HPV in...

Dr Kofi Effah, Catholic Hospital, Battor, Ghana

Using a novel cervical precancer screening approach to detect HPV in incarcerated women in Ghana ( Dr Kofi Effah, Catholic Hospital, Battor, Ghana )

Real world evidence on the use of antibody drug conjugates in peripheral T-cell...

Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut...

Real world evidence on the use of antibody drug conjugates in peripheral T-cell lymphoma ( Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Lebanon )

More from ecancer